- Are we there yet? more
- Are Web Development Methods Too Difficult To Use? more
- Are well‐intended Buddhist practices an under‐appreciated threat to global aquatic biodiversity? more
- Are women's expectations and preferences for intrapartum care affected by the model of care on offer? more
- Are you anonymous? Social-psychological processes of hacking groups more
- Are you ready for your child, the 3D printing genius? more
- Are You There more
- Are You There: Material and Immaterial more
- Are You There: the relationship between film and screen more
- Are You There? more
- ARElight: Context Sampling of Large Texts for Deep Learning Relation Extraction more
- ARFDNet: An efficient activity recognition & fall detection system using latent feature pooling more
- Arm motion monitoring and recovery assessment device more
- Arming the citizen-consumer: the invention of ‘media literacy’ within UK communications policy more
- Arnold, Doris Grace (1904-1969), radio presenter and producer more
- Arsenic in the bengal delta plain: Geochemical complications and potential mitigation option more
- Arsenic mobilization in the aquifers of three physiographic settings of West Bengal, India: understanding geogenic and anthropogenic influences. more
- Art in corporate governance: A Deweyan perspective on board experience more
- Art in corporate governance: A Deweyan perspective on board experience more
- Art in Motion: current research in screendance more
- Art Park Space more
- ART: Ankle Recovery Trial Protocol v 1.6 more
- ARTemis: A randomised trial of bevacizumab with neo-adjuvant chemotherapy (NACT) for patients with HER2-negative early breast cancer: primary endpoint – pathological complete response (pCR) more
- ARTemis: A randomised trial of bevacizumab with neo-adjuvant chemotherapy (NACT) for patients with HER2-negative early breast cancer: primary endpoint – pathological complete response (pCR). more
- ARTemis: A randomised trial of bevacizumab with neo-adjuvant chemotherapy for patients with HER2-negative early breast cancer more